Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis
- PMID: 20034760
- DOI: 10.1016/j.jaut.2009.12.001
Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis
Abstract
Psoriasis and Psoriatic Arthritis (PsA) are chronic inflammatory diseases that have a major impact on health. The prevalence and incidence estimates of these two closely related diseases show ethnic and geographic variations, being generally more common in the colder north than in the tropics. In Europe the prevalence of psoriasis varies anywhere from 0.6 to 6.5%. In the USA, the estimated prevalence of diagnosed psoriasis is 3.15%. The prevalence in Africa varies depending on geographic location, being lowest in West Africa. Psoriasis is less prevalent in China and Japan than in Europe, and is entirely absent in natives of the Andean region of South America. There are fewer reports on the incidence of psoriasis, but a recent study from Rochester, USA showed an increasing trend over the last 2 decades. The prevalence of PsA also shows similar variation, being highest in people of European descent and lowest in the Japanese. Although, study methodology and case definition may explain some of the variations, genetic and environmental factors are important. Genetic epidemiologic studies have shown that both diseases have a strong genetic component. The strongest association is with HLA-Cw*06. Associations with a number of genes including IL12B and IL23R have recently been confirmed. Environmental risk factors including streptococcal pharyngitis, stressful life events, low humidity, drugs, HIV infection, trauma, smoking and obesity have been associated with psoriasis and PsA. Here we have reviewed the current literature on the epidemiology and genetics of psoriasis and PsA.
Published by Elsevier Ltd.
Similar articles
-
The genetics of psoriasis and psoriatic arthritis.Clin Rev Allergy Immunol. 2013 Apr;44(2):149-56. doi: 10.1007/s12016-012-8303-5. Clin Rev Allergy Immunol. 2013. PMID: 22274791 Review.
-
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci.PLoS Genet. 2008 Mar 28;4(3):e1000041. doi: 10.1371/journal.pgen.1000041. PLoS Genet. 2008. PMID: 18369459 Free PMC article.
-
Genetics of psoriasis and psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.J Rheumatol. 2012 Feb;39(2):431-3. doi: 10.3899/jrheum.111242. J Rheumatol. 2012. PMID: 22298274 Free PMC article.
-
Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset.Clin Exp Rheumatol. 2012 Jul-Aug;30(4):476-80. Epub 2012 Aug 29. Clin Exp Rheumatol. 2012. PMID: 22510299
-
The genetics of psoriatic arthritis: lessons from genome-wide association studies.Discov Med. 2010 Sep;10(52):177-83. Discov Med. 2010. PMID: 20875338 Review.
Cited by
-
Ustekinumab improves psoriasis without altering T cell cytokine production, differentiation, and T cell receptor repertoire diversity.PLoS One. 2012;7(12):e51819. doi: 10.1371/journal.pone.0051819. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251632 Free PMC article.
-
Effect of ethnicity on disease activity and physical function in psoriatic arthritis in a multiethnic Asian population.Clin Rheumatol. 2017 Jan;36(1):125-131. doi: 10.1007/s10067-016-3460-1. Epub 2016 Oct 30. Clin Rheumatol. 2017. PMID: 27796663
-
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial.Br J Dermatol. 2021 Jan;184(1):50-59. doi: 10.1111/bjd.19341. Epub 2020 Sep 6. Br J Dermatol. 2021. PMID: 32594522 Free PMC article. Clinical Trial.
-
Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Clin Rev Allergy Immunol. 2013 Apr;44(2):121-40. doi: 10.1007/s12016-012-8301-7. Clin Rev Allergy Immunol. 2013. PMID: 22311162 Review.
-
Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers.Int J Mol Sci. 2023 Jan 12;24(2):1527. doi: 10.3390/ijms24021527. Int J Mol Sci. 2023. PMID: 36675037 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous